Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | General Counsel | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to buy Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2036-08-04 | Direct | 250,000 |
Reported balance
After 2026-08-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 250,000 · Balance 250,000 F1: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030 |
Filing footnotes · ownership attribution and instrument terms
F1: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:52 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantOptions to buy Common Stock · Derivative | 250,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001654954-26-007396 · section16.xml · derivative · entry 1 DeHaan-Fullerton Karen · CIK 0001934689 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2036-08-04 F1 · derivative.exercise_date: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030 Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:00 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantOptions to buy Common Stock · Derivative | 500,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001654954-25-007004 · section16.xml · derivative · entry 1 DeHaan-Fullerton Karen · CIK 0001934689 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029 Read SEC document |
| May 19, 2025 Filed May 20, 2025 20:01 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 104,300 | $0.05 | $5,006.40 |
DisclosureSEC source: 0001654954-25-005944 · section16.xml · nonDerivative · entry 1 DeHaan-Fullerton Karen · CIK 0001934689 · General Counsel/Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,300 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:08 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 500,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014266 · section16.xml · derivative · entry 1 DeHaan-Fullerton Karen · CIK 0001934689 · General Counsel/Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common · 500,000 shares Expires 2034-11-10 F1 · derivative.exercise_date: one fourth of the options vest on the first anniversary of the grant date and 1/48 vest each month thereafter until fully vested on 11/10/2028 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.